ASPM and central nervous system cancer: More importantly, further validation in the CGGA and TCGA‐LGG data sets and clinical samples also demonstrated that the expression of ASPM mRNA was increased with the increase in glioma grades, and the high expression of ASPM indicated a worse prognosis (Figure 1C,D).